Attention Deficit Disorder with Hyperactivity

8 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Mental Disorders, Neurodevelopmental Disorders

Treatments and conditions

Attention Deficit Disorder with Hyperactivity
Treatment and conditionWhere it standsTrials
Academic Competency Enhancement (ACE) classroom for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
EB-1020 (Centanafadine) high dose for attention deficit disorder with hyperactivityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
EB-1020 (Centanafadine) low dose for attention deficit disorder with hyperactivityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbiota Transplant (FMT) for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbiota Transplant (FMT) + Vancomycin + NITAZOXANIDE for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Lysergide d-tartrate for attention deficit disorder with hyperactivityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Vancomycin + NITAZOXANIDE for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Viloxazine hydrochloride for attention deficit disorder with hyperactivityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.